{"Abstract": [0], "In": [1], "recent": [2], "years,": [3], "immunotherapy": [4, 141, 184], "represented": [5], "by": [6, 34], "immune": [7, 49, 115, 124], "checkpoint": [8], "inhibitors": [9], "(ICIs)": [10], "has": [11], "led": [12], "to": [13, 30, 58, 75, 151, 179], "unprecedented": [14], "breakthroughs": [15], "in": [16, 64, 138, 148, 185], "cancer": [17, 65, 90], "treatment.": [18], "However,": [19], "the": [20, 35, 43, 98, 156, 172, 181], "fact": [21], "that": [22, 55], "many": [23], "tumors": [24, 51, 54, 149], "respond": [25, 57], "poorly": [26], "or": [27, 130], "even": [28, 147], "not": [29], "ICIs,": [31], "partly": [32], "caused": [33], "absence": [36], "of": [37, 45, 73, 79, 176, 183], "tumor-infiltrating": [38], "lymphocytes": [39], "(TILs),": [40], "significantly": [41], "limits": [42], "application": [44, 175], "ICIs.": [46, 152], "Converting": [47], "these": [48], "\u201ccold\u201d": [50], "into": [52], "\u201chot\u201d": [53], "may": [56, 142], "ICIs": [59], "is": [60, 69, 85], "an": [61], "unsolved": [62], "question": [63], "immunotherapy.": [66], "Since": [67], "it": [68], "a": [70, 88], "general": [71], "characteristic": [72], "cancers": [74], "resist": [76], "apoptosis,": [77], "induction": [78], "non-apoptotic": [80, 101, 163, 177], "regulated": [81], "cell": [82], "death": [83], "(RCD)": [84], "emerging": [86], "as": [87], "new": [89], "treatment": [91], "strategy.": [92], "Recently,": [93], "several": [94], "studies": [95], "have": [96], "revealed": [97], "interaction": [99], "between": [100, 159], "RCD": [102, 178], "and": [103, 110, 136, 162, 169, 171], "antitumor": [104, 114, 123, 145, 160], "immunity.": [105], "Specifically,": [106], "autophagy,": [107, 133, 166], "ferroptosis,": [108, 134, 167], "pyroptosis,": [109, 135, 168], "necroptosis": [111, 137], "exhibit": [112], "synergistic": [113], "responses": [116], "while": [117], "possibly": [118], "exerting": [119], "inhibitory": [120], "effects": [121], "on": [122], "responses.": [125], "Thus,": [126], "targeted": [127], "therapies": [128], "(inducers": [129], "inhibitors)": [131], "against": [132], "combination": [139], "with": [140], "exert": [143], "potent": [144], "activity,": [146], "resistant": [150], "This": [153], "review": [154], "summarizes": [155], "multilevel": [157], "relationship": [158], "immunity": [161], "RCD,": [164], "including": [165], "necroptosis,": [170], "potential": [173], "targeting": [174], "improve": [180], "efficacy": [182], "malignancy.": [186]}